This House resolution expresses the chamber’s support for the goals and ideals of a Creutzfeldt-Jakob Disease (CJD) Awareness Day. It does not appropriate funds or create new regulatory authorities; it is a formal statement intended to elevate attention to CJD and related prion diseases.
The resolution frames CJD as a rare, fatal brain disorder that creates rapid caregiving and diagnostic challenges, and it calls out the need for surveillance and research into whether certain animal prion diseases pose risks to humans. For professionals, the text signals congressional recognition of surveillance gaps and a desire to connect prion-disease work with broader dementia research and caregiver support efforts.
At a Glance
What It Does
The bill is a nonbinding House resolution that formally supports the establishment of a CJD Awareness Day and recognizes the disease’s public-health implications. It lists findings about incidence, disease progression, and the importance of surveillance and pathology review but does not direct agencies or allocate money.
Who It Affects
Patients with CJD and their families, neurologists and dementia-care providers, the National Prion Disease Pathology Surveillance Center, public-health laboratories, and state wildlife and agricultural agencies monitoring chronic wasting disease (CWD) will see increased congressional attention. Advocacy groups and researchers studying prion and dementia biology are likely to use the day for outreach and fundraising.
Why It Matters
Symbolic resolutions can change the priorities of grantmakers, journal editors, and agencies by signposting issues for stakeholders. Here, the resolution elevates surveillance and postmortem brain examination as priorities and links prion disease study to Alzheimer’s and related dementia research, which may shift research collaborations and messaging.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The resolution collects a brief set of congressional findings about Creutzfeldt-Jakob Disease and then adopts two short operative statements: it supports the goals and ideals of an awareness day and recognizes the importance of raising awareness. The findings describe CJD as a prion disease that progresses rapidly to death, and they emphasize surveillance and diagnostic pathology as crucial public-health tools.
The text cites incidence and mortality estimates, explains that most cases are sporadic while a minority are genetic or acquired, and calls for continued examination of human brain tissue after death to improve detection and classification. It names the National Prion Disease Pathology Surveillance Center as the only laboratory-based organization in the United States that monitors human prion diseases, and it flags chronic wasting disease in cervids—detected in more than three dozen states—as a surveillance concern because of unresolved questions about animal-to-human transmission.Beyond disease-count details, the resolution draws a practical connection between prion-disease work and Alzheimer’s and related dementia (ADRD) research: it argues that neuropathology and caregiver-service research used in ADRD could be applied to prion diseases.
The operative language is declarative rather than prescriptive: it does not require federal agencies to change practice, nor does it create funding streams, but it provides a formal congressional statement that advocates and researchers can cite when seeking attention or resources.Finally, the resolution designates a specific date for the awareness day in 2025. Because the measure is a simple House resolution, its immediate legal effect is symbolic; the immediate operational impact depends on how agencies, foundations, and advocacy organizations respond to the added visibility and congressional framing.
The Five Things You Need to Know
The resolution designates November 12, 2025, as 'Creutzfeldt-Jakob Disease (CJD) Awareness Day.', It cites an incidence of approximately 1 to 2 CJD cases per million people per year—about 600 cases in the United States annually—and notes that 85% of those are sporadic, 10–15% are genetic, and fewer than 1% are acquired.
The text states that CJD typically leads to death within a few months to one year after symptom onset and attributes roughly 1 in 6,000 U.S. deaths annually to CJD.
The resolution identifies the National Prion Disease Pathology Surveillance Center as the only U.S. laboratory-based organization that monitors human prion diseases, highlighting its central role for postmortem diagnosis.
It flags chronic wasting disease (CWD) in cervids—detected in over 36 states and in all four U.S. regions—and explicitly ties continued postmortem brain surveillance to evaluating potential transmission risks to humans.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Congressional findings on incidence, progression, and surveillance needs
The preamble collects facts the House attributes to CJD: incidence estimates, clinical progression (from memory and coordination problems to coma), and mortality. Practically, those findings serve as a statement of congressional concern that can be cited by public-health officials and advocates to justify heightened surveillance, neuropathology capacity, or informational campaigns. The findings also single out specific surveillance targets—postmortem brain examination and links to animal prion diseases—signaling priorities without creating mandates.
Support for the goals and ideals of a CJD Awareness Day
This operative sentence formally expresses the House’s support for an awareness day. As a simple resolution, it conveys political support and visibility rather than creating enforceable duties. Its immediate effect is to provide an official congressional endorsement that advocacy groups and institutions can reference in outreach, fundraising, and awareness events.
Recognition of the importance of raising awareness
The second operative clause recognizes the need to increase public and professional awareness of CJD. That recognition links prion disease awareness to broader dementia-care frameworks and to surveillance imperatives. Because the clause contains no funding or regulatory text, its practical import depends on downstream actors—research funders, public-health officials, and clinical organizations—deciding to act on the House’s framing.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Patients with CJD and their families — increased visibility can improve access to specialist information, support networks, and resources for end-of-life and rapid-progressing dementia care.
- National Prion Disease Pathology Surveillance Center — congressional recognition raises the center’s profile, which could help secure philanthropic support or justify expanded lab capacity and staffing.
- Neurology and dementia researchers — the resolution explicitly links prion-disease study to Alzheimer’s and related dementia research, encouraging cross-disciplinary collaboration and potential data sharing.
- Advocacy groups and caregiver organizations — an awareness day provides a focal point for fundraising, education campaigns, and policy advocacy targeted at surveillance and caregiver supports.
- Public-health and wildlife surveillance programs — by spotlighting CWD and postmortem surveillance, the resolution can prompt state and federal programs to prioritize testing and monitoring efforts.
Who Bears the Cost
- Federal and state public-health laboratories — heightened expectations for neuropathology or expanded surveillance could increase workload and require resources that are not provided by the resolution.
- National Prion Disease Pathology Surveillance Center — while benefiting from attention, the center may face requests to expand services without accompanying funding or staff increases.
- State wildlife and agricultural agencies — increased public and congressional attention to CWD could translate into political pressure to expand cervid testing and containment programs, with budgetary effects.
- Hospitals and pathology services — calls for more postmortem brain examinations create logistical and consent challenges that may impose costs on clinical institutions and medical examiners.
Key Issues
The Core Tension
The bill balances the legitimate public-health need to improve detection and understanding of rare but fatal prion diseases against the reality that symbolic recognition alone cannot fund laboratory capacity, resolve scientific uncertainty about animal-to-human risk, or address the logistical and ethical challenges of increased postmortem surveillance. The central dilemma is whether added visibility will catalyze necessary resources and evidence-based action or will instead generate expectation and pressure that outstrips the available scientific and operational capacity.
The resolution is symbolic: it lists findings and expresses support but does not authorize spending, change statute, or impose operational requirements. That limits immediate policy effect while leaving open whether agencies, funders, or advocacy organizations will convert attention into action.
The choice to name a single national center as the only laboratory-based monitor underscores a potential vulnerability in U.S. prion surveillance — namely, concentration of expertise and data in one place — and raises questions about redundancy and surge capacity if surveillance demand grows.
The text emphasizes postmortem brain examination as critical for surveillance, yet it does not address the practical hurdles: consent processes, biosafety requirements for handling prion-infected tissue, reimbursement for pathology work, or the capacity of medical examiner systems. The resolution also calls out CWD presence in wildlife and the need to evaluate zoonotic risk, but it provides no scientific standard for when surveillance findings would change human-health guidance.
That gap could generate public alarm or pressure on agriculture and hunting sectors without a clear evidence-based trigger for policy responses.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.